AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company. In 2013, it moved its headquarters to Cambridge, UK, and concentrated its R&D in three sites: Cambridge; Gaithersburg, Maryland, USA for work on biopharmaceuticals; and Mölndal in Sweden, for research on traditional chemical drugs. Read More
Switzerland does not have sufficient data to approve the use of the coronavirus vaccine developed by the UK-Swedish AstraZeneca pharmaceutical company, the government said on Wednesday. ...
India's Serum Institute will be supplying 1.1 billion doses of coronavirus vaccines developed by AstraZeneca and Novavax to around 100 countries for approximately USD 3 per dose for the low and lower-middle-income countries, said Henrietta Fore, Unit ...
New Zealand authorised emergency use of the Pfizer/BioNTech coronavirus vaccine on Wednesday, with a view to receiving the first shipment by April. ...
French President Emmanuel Macron has pledged that all French residents who wish to be vaccinated against COVID-19 will be able to do so by the end of the summer. ...
India is the key production partner for Russia's Sputnik V vaccine against the coronavirus, Kirill Dmitriev, Chief Executive Officer (CEO) of Russian Direct Investment Fund (RDIF) said on Tuesday. ...
The Department of Health (DOH) of the Philippines reported on Sunday 2,103 new COVID-19 cases, bringing the total number of confirmed cases in the Southeast Asian country to 525,618. ...
